Filana Therapeutics
FLNA
87 hedge funds and large institutions have $154M invested in Filana Therapeutics in 2014 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 21 reducing their positions, and 12 closing their positions.
5,000% more call options, than puts
Call options by funds: $612K | Put options by funds: $12K
100% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 12
43% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 21
16% more funds holding
Funds holding: 75 → 87 (+12)
13% more capital invested
Capital invested by funds: $137M → $154M (+$17.2M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.44M |
| 2 |
First Eagle Investment Management
New York
|
+$4.29M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.76M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.79M |
| 5 |
MSP
Madison Street Partners
Denver,
Colorado
|
+$1.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$4.29M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.13M |
| 3 |
6CM
683 Capital Management
New York
|
-$880K |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$808K |
| 5 |
GCM
Gruss Capital Management
New York
|
-$739K |
FLNA Hedge Fund Activity: Q2 2014 in Review
87 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2014, worth a combined $154M — up 13% from $137M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new FLNA positions and 12 closed out — a net gain of 12 holders — while 30 added to existing stakes and 21 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $4.44M. The largest seller was Broadfin Capital, exiting entirely with an estimated $4.29M sold.
- 87 institutional investors held Filana Therapeutics (FLNA) as of Q2 2014, up from 75 in Q1 2014.
- Funds reported $154M of Filana Therapeutics stock for Q2 2014, up 13% quarter-over-quarter.
- 24 funds opened new Filana Therapeutics positions in Q2 2014 and 12 closed out, a net change of +12 holders.
- The largest Filana Therapeutics buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $4.44M added.
- The largest Filana Therapeutics seller in Q2 2014 was Broadfin Capital, an estimated $4.29M sold.
Based on aggregated 13F filings for Q2 2014.